Importance of Local Experts on the Ground
Hear from a team of FHI Clinical experts as they discuss the importance of having localized expertise on the ground to build research capacity and site sustainability.
Action Items From the PREVAIL Network Site Visit
Watch this video to learn about the action items put into place following a visit to each of the PREVAIL network sites in Liberia, such as implementing productivity metrics and clarifying roles and responsibilities.
Training, Knowledge and Skills for the PREVAIL Network Site Staff
Following a trip to the PREVAIL network of sites in Liberia, we asked FHI Clinical team members for their feedback on the types of training, knowledge and skills that are important for the site staff to encompass. Watch this video to learn what qualities the experts evaluated during their trip.
Takeaways From the PREVAIL Network Trip
Upon their return from visiting Liberia and the PREVAIL network sites, we asked a team of FHI Clinical experts what they learned during their time in the country.
Purpose of the Visit to the PREVAIL Network in Liberia
In the fall of 2021, a small team from FHI Clinical headed to Liberia to meet the FHI Clinical PREVAIL network team. Watch this video to learn more about the purpose and goals of their trip.
About the PREVAIL Network
The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.
Our Clinical Trial Experience With Ebola Virus Disease
Since 1976, Ebola virus disease outbreaks have primarily occurred in eleven countries: Democratic Republic of the Congo, Gabon, Guinea, Liberia, Mali, Nigeria, Republic of Congo, Sierra Leone, Sudan and Uganda. Although it is generally rare, it is often fatal, with death rates ranging from 25 to 90% in past outbreaks (average case fatality rate, 50%). No treatment or vaccine is currently approved, but there are several promising vaccines and treatments under development.
Successful Outbreak Responses Depend On Reliable Data
In this webinar, industry veterans Michelle Berrey, MD, MPH, and Claudia Christian discuss the importance of quality data for a successful outbreak response plan.
8 Key Lessons for Outbreak Responses
Outbreaks large and small require rapid, coordinated responses. In this infographic, we describe eight considerations for outbreak responses, based on the collective experience of our experts.
What Can We Learn From Past Outbreaks?
Outbreaks large and small require rapid, coordinated responses. In this e-book, we describe eight considerations for outbreak responses, based on the collective experience of our experts.
